Integrated in vitro, in vivo, and in silico evaluation of antidiabetic and anti-inflammatory activities of Melia azedarach stem bark extract

This study investigated the anti-inflammatory and anti-diabetic potential of Melia azedarach stem bark extract (MASBE) using integrated in vitro, in vivo, and in silico approaches. Anti-diabetic activity was assessed through yeast glucose uptake, glucose adsorption, α-amylase, and α-glucosidase inhibition assays, followed by evaluation in an alloxan-induced diabetic mouse model. Anti-inflammatory activity was evaluated by human red blood cell (HRBC) membrane stabilization, heat-induced hemolysis, protein denaturation assays, and an in vivo xylene-induced ear edema model in mice. Molecular docking investigated the interactions of major phytoconstituents with inflammatory targets (COX-1, COX-2, and 5-LOX) and the anti-diabetic target AMPK. The extract showed potent anti-diabetic effects, including maximum yeast glucose uptake (78.99%), α-amylase inhibition (76.72%), and α-glucosidase inhibition (74.53%), along with effective glucose adsorption. In diabetic mice, MASBE significantly reduced blood glucose levels and improved body weight and pancreatic and liver histology. MASBE exhibited significant dose-dependent anti-inflammatory activity, achieving maximum inhibition of 63.76% in HRBC membrane stabilization, 56.09% in heat-induced hemolysis, and 69.69% in protein denaturation assays, while markedly reducing xylene-induced ear edema in mice. Molecular docking revealed favorable binding affinities of α-linolenic acid, protocatechuic acid, and cyanidin-3-O-β-D-glucoside toward inflammatory and diabetic targets, with docking scores ranging from −3.72 to −6.85 kcal/mol, supported by key hydrogen-bond interactions. The combined experimental and computational findings demonstrate that MASBE possesses potent anti-inflammatory and anti-diabetic activities. These effects are likely mediated through multiple mechanisms involving inhibition of inflammatory mediators and modulation of glucose metabolism, highlighting M. azedarach stem bark as a promising natural source for the development of multifunctional therapeutic agents.

Authors

Publication Details

Journal
Atlantic Journal of Life Sciences
Published
2026-11-14
DOI
https://doi.org/10.71005/e1prqf61
Primary Topic
Natural Antidiabetic Agents Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Integrated in vitro, in vivo, and in silico evaluation of antidiabetic and anti-inflammatory activities of Melia azedarach stem bark extract

Gauhar Rehman, Adil Sher, Ali Shan, Adnan Gul et al.
Atlantic Journal of Life Sciences
Natural Antidiabetic Agents Studies
article

Integrated in vitro, in vivo, and in silico evaluation of antidiabetic and anti-inflammatory activities of Melia azedarach stem bark extract

Gauhar Rehman, Adil Sher, Ali Shan, Adnan Gul, Muhammad Shahab Shahab, Shahab Ud Din, Bushra Haider, Irfan Ullah, Muhammad Tauqeer
article en

Abstract

This study investigated the anti-inflammatory and anti-diabetic potential of Melia azedarach stem bark extract (MASBE) using integrated in vitro, in vivo, and in silico approaches. Anti-diabetic activity was assessed through yeast glucose uptake, glucose adsorption, α-amylase, and α-glucosidase inhibition assays, followed by evaluation in an alloxan-induced diabetic mouse model. Anti-inflammatory activity was evaluated by human red blood cell (HRBC) membrane stabilization, heat-induced hemolysis, protein denaturation assays, and an in vivo xylene-induced ear edema model in mice. Molecular docking investigated the interactions of major phytoconstituents with inflammatory targets (COX-1, COX-2, and 5-LOX) and the anti-diabetic target AMPK. The extract showed potent anti-diabetic effects, including maximum yeast glucose uptake (78.99%), α-amylase inhibition (76.72%), and α-glucosidase inhibition (74.53%), along with effective glucose adsorption. In diabetic mice, MASBE significantly reduced blood glucose levels and improved body weight and pancreatic and liver histology. MASBE exhibited significant dose-dependent anti-inflammatory activity, achieving maximum inhibition of 63.76% in HRBC membrane stabilization, 56.09% in heat-induced hemolysis, and 69.69% in protein denaturation assays, while markedly reducing xylene-induced ear edema in mice. Molecular docking revealed favorable binding affinities of α-linolenic acid, protocatechuic acid, and cyanidin-3-O-β-D-glucoside toward inflammatory and diabetic targets, with docking scores ranging from −3.72 to −6.85 kcal/mol, supported by key hydrogen-bond interactions. The combined experimental and computational findings demonstrate that MASBE possesses potent anti-inflammatory and anti-diabetic activities. These effects are likely mediated through multiple mechanisms involving inhibition of inflammatory mediators and modulation of glucose metabolism, highlighting M. azedarach stem bark as a promising natural source for the development of multifunctional therapeutic agents.

Atlantic Journal of Life SciencesVol. 2026(1)
Natural Antidiabetic Agents Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon